AAAAAA
Results:
1-19
|
Results: 19
Authors:
Schmidt-Ullrich, R
Aebischer, T
Hulsken, J
Birchmeier, W
Klemm, U
Scheidereit, C
Citation: R. Schmidt-ullrich et al., Requirement of NF-kappa B/Rel for the development of hair follicles and other epidermal appendices, DEVELOPMENT, 128(19), 2001, pp. 3843-3853
Authors:
Muller, DN
Heissmeyer, V
Dechend, R
Hampich, F
Park, JK
Fiebeler, A
Shagdarsuren, E
Theuer, J
Elger, M
Pilz, B
Breu, V
Schroer, K
Ganten, D
Dietz, R
Haller, H
Scheidereit, C
Luft, FC
Citation: Dn. Muller et al., Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage, FASEB J, 15(8), 2001, pp. NIL_117-NIL_135
Authors:
Wuchter, C
Krappmann, D
Cai, Z
Ruppert, V
Scheidereit, C
Dorken, B
Ludwig, WD
Karawajew, L
Citation: C. Wuchter et al., In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity, LEUKEMIA, 15(6), 2001, pp. 921-928
Authors:
Heissmeyer, V
Krappmann, D
Hatada, EN
Scheidereit, C
Citation: V. Heissmeyer et al., Shared pathways of I kappa B kinase-induced SCF beta TrCP-mediated ubiquitination and degradation for the NF-kappa B precursor p105 and I kappa B alpha, MOL CELL B, 21(4), 2001, pp. 1024-1035
Authors:
Krappmann, D
Patke, A
Heissmeyer, V
Scheidereit, C
Citation: D. Krappmann et al., B-cell receptor- and phorbol ester-induced NF-kappa B and c-Jun N-terminalkinase activation in B cells requires novel protein kinase C's, MOL CELL B, 21(19), 2001, pp. 6640-6650
Authors:
Hinz, M
Loser, P
Mathas, S
Krappmann, D
Dorken, B
Scheidereit, C
Citation: M. Hinz et al., Constitutive NF-kappa B maintains high expression of a characteristic genenetwork, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells, BLOOD, 97(9), 2001, pp. 2798-2807
Authors:
Slaugenhaupt, SA
Blumenfeld, A
Gill, SP
Leyne, M
Mull, J
Cuajungco, MP
Liebert, CB
Chadwick, B
Idelson, M
Reznik, L
Robbins, CM
Makalowska, I
Brownstein, MJ
Krappmann, D
Scheidereit, C
Maayan, C
Axelrod, FB
Gusella, JF
Citation: Sa. Slaugenhaupt et al., Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia, AM J HU GEN, 68(3), 2001, pp. 598-605
Authors:
Lange, K
Kleuser, B
Gysler, A
Bader, M
Maia, C
Scheidereit, C
Korting, HC
Schafer-Korting, M
Citation: K. Lange et al., Cutaneous inflammation and proliferation in vitro: Differential effects and mode of action of topical glucocorticoids, SKIN PH APP, 13(2), 2000, pp. 93-103
Authors:
Hatada, EN
Krappmann, D
Scheidereit, C
Citation: En. Hatada et al., NF-kappa B and the innate immune response, CURR OP IM, 12(1), 2000, pp. 52-58
Authors:
Kordes, U
Krappmann, D
Heissmeyer, V
Ludwig, WD
Scheidereit, C
Citation: U. Kordes et al., Transcription factor NF-kappa B is constitutively activated in acute lymphoblastic leukemia cells, LEUKEMIA, 14(3), 2000, pp. 399-402
Authors:
Hehner, SP
Hofmann, TG
Ushmorov, A
Dienz, O
Leung, IWL
Lassam, N
Scheidereit, C
Droge, W
Schmitz, ML
Citation: Sp. Hehner et al., Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the I kappa B kinase complex, MOL CELL B, 20(7), 2000, pp. 2556-2568
Authors:
Krappmann, D
Hatada, EN
Tegethoff, S
Li, J
Klippel, A
Giese, K
Baeuerle, PA
Scheidereit, C
Citation: D. Krappmann et al., The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component, J BIOL CHEM, 275(38), 2000, pp. 29779-29787
Authors:
Hatada, EN
Chen-Kiang, S
Scheidereit, C
Citation: En. Hatada et al., Interaction and functional interference of C/EBP beta with octamer factorsin immunoglobulin gene transcription, EUR J IMMUN, 30(1), 2000, pp. 174-184
Authors:
Krappmann, D
Emmerich, F
Kordes, U
Scharschmidt, E
Dorken, B
Scheidereit, C
Citation: D. Krappmann et al., Molecular mechanisms of constitutive NF-kappa B/Rel activation in Hodgkin/Reed-Sternberg cells, ONCOGENE, 18(4), 1999, pp. 943-953
Authors:
Dechend, R
Hirano, F
Lehmann, K
Heissmeyer, V
Ansieau, S
Wulczyn, FG
Scheidereit, C
Leutz, A
Citation: R. Dechend et al., The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel andnuclear co-regulators, ONCOGENE, 18(22), 1999, pp. 3316-3323
Authors:
Hinz, M
Krappmann, D
Eichten, A
Heder, A
Scheidereit, C
Strauss, M
Citation: M. Hinz et al., NF-kappa B function in growth control: Regulation of cyclin D1 expression and G(0)G(1)-to-S-Phase transition, MOL CELL B, 19(4), 1999, pp. 2690-2698
Authors:
Heissmeyer, V
Krappmann, D
Wulczyn, FG
Scheidereit, C
Citation: V. Heissmeyer et al., NF-kappa B p105 is a target of I kappa B kinases and controls signal induction of Bcl-3-p50 complexes, EMBO J, 18(17), 1999, pp. 4766-4778
Authors:
Dechend, R
Maass, M
Gieffers, J
Dietz, R
Scheidereit, C
Leutz, A
Gulba, DC
Citation: R. Dechend et al., Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis, CIRCULATION, 100(13), 1999, pp. 1369-1373
Authors:
Emmerich, F
Meiser, M
Hummel, M
Demel, G
Foss, HD
Jundt, F
Mathas, S
Krappmann, D
Scheidereit, C
Stein, H
Dorken, B
Citation: F. Emmerich et al., Overexpression of I kappa B alpha without inhibition of NF-kappa B activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells, BLOOD, 94(9), 1999, pp. 3129-3134
Risultati:
1-19
|